{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:04:18Z","timestamp":1790910258137,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study was to assess the feasibility and acceptability of the next-generation wrist-worn receiver (\u201cReader\u201d) coupled with the ID-Cap digital pill system (DPS) to measure adherence to oral HIV PrEP (pre-exposure prophylaxis) via an ingestible radiofrequency sensor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective cohort study enrolled 15 participants who were prescribed oral tenofovir diphosphate\/emtricitabine (TDF\/FTC) as PrEP. Participants were asked to ingest one digital pill daily for 30 days. Adherence was also measured using pill counts at the 30-day follow-up visit, which was compared to DPS-recorded ingestions (including both system-detected and manually annotated ingestions). The primary outcomes were system feasibility, defined as the ability of participants to engage with and operate the DPS throughout the 30-day study period and acceptability, as reported via the System Usability Scale (SUS). Qualitative interviews were conducted to receive feedback from the participants. The secondary outcome was the accuracy of the DPS, measured via a Pearson correlation comparing system-detected ingestions with pill count at 30-day follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>14 participants consistently recorded ingestions using the DPS over the 30-day study period, demonstrating feasibility of the system. A technical error occurred on one participant\u2019s wrist-worn Reader that rendered it unable to detect ingestions. Weekly engagement remained consistent across the study period. N\u00a0=\u00a012 participants returned pills at the final study visit. Based on pill count, 343 doses were ingested overall; 278 doses (81%) were detected by the DPS. DPS-based detection was strongly correlated with pill counts (r=0.75, p=0.0047). Participants had a mean SUS score of 78.0 (\u00b1 9.4), indicating good acceptability of the system. Qualitative feedback demonstrated good usability and convenience of operating the DPS. For N\u00a0=\u00a06 participants who had previously used a lanyard-based DPS Reader, all preferred the new wrist-worn system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A wrist-worn ingestible sensor system is acceptable and feasible among individuals to record PrEP adherence. The system is accurate in detecting ingestion events, in comparison to more traditional measures of adherence, and individuals can maintain engagement with the system over time. These findings warrant further evaluation in larger studies but strongly suggest that wrist-based form factors are suitable for integration into DPS technology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1550058","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:56:02Z","timestamp":1778853362000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Feasibility, acceptability, and user perspective of a next-generation wrist-worn receiver and digital pills for HIV pre-exposure prophylaxis: a pilot study"],"prefix":"10.3389","volume":"17","author":[{"given":"Dhruv","family":"Nimbalkar","sequence":"first","affiliation":[{"name":"The Fenway Institute, Fenway Health","place":["Boston, MA, United States"]},{"name":"Boston University School of Public Health","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. R.","family":"Goodman","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health","place":["Boston, MA, United States"]},{"name":"Department of Emergency Medicine, Brigham and Women\u2019s Hospital","place":["Boston, MA, United States"]},{"name":"Department of Psychiatry, Massachusetts General Hospital","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hokayem","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Albrechta","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Loo","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Lee","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health","place":["Boston, MA, United States"]},{"name":"Department of Psychiatry, Massachusetts General Hospital","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"Goldfine","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Brigham and Women\u2019s Hospital","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"O\u2019Cleirigh","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health","place":["Boston, MA, United States"]},{"name":"Department of Psychiatry, Massachusetts General Hospital","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mayer","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health","place":["Boston, MA, United States"]},{"name":"Department of Medicine, Beth Israel Deaconess Medical Center","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Alpert","sequence":"additional","affiliation":[{"name":"EtectRx","place":["Gainesville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Carnes","sequence":"additional","affiliation":[{"name":"EtectRx","place":["Gainesville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. R.","family":"Chai","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Fenway Health","place":["Boston, MA, United States"]},{"name":"Department of Emergency Medicine, Brigham and Women\u2019s Hospital","place":["Boston, MA, United States"]},{"name":"Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute","place":["Boston, MA, United States"]},{"name":"The Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"B1","unstructured":"Ending the HIV epidemic\n          \n          \n          \n          2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000002407","article-title":"Brief report: Associations between self-reported substance use behaviors and PrEP acceptance and adherence among Black MSM in the HPTN 073 study","volume":"85","author":"Okafor","year":"2020","journal-title":"Jaids J Acquired Immune Deficiency Syndromes"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1186\/s12889-020-09883-z","article-title":"Alcohol consumption, substance use, and depression in relation to HIV Pre-Exposure Prophylaxis (PrEP) nonadherence among gay, bisexual, and other men-who-have-sex-with-men","volume":"20","author":"Shuper","year":"2020","journal-title":"BMC Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/coh.0000000000000733","article-title":"Promises and challenges: cabotegravir for preexposure prophylaxis","volume":"17","author":"Spinelli","year":"2022","journal-title":"Curr Opin HIV AIDS"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3018(23)00079-6","article-title":"The future of HIV pre-exposure prophylaxis adherence: reducing barriers and increasing opportunities","volume":"10","author":"Haberer","year":"2023","journal-title":"Lancet HIV"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-020-00502-5","article-title":"Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions","volume":"17","author":"Spinelli","year":"2020","journal-title":"Curr Hiv\/Aids Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-015-0494-8","article-title":"Utilizing an ingestible biosensor to assess real-time medication adherence","volume":"11","author":"Chai","year":"2015","journal-title":"J Med Toxicol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01710-17","article-title":"Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy","volume":"62","author":"Anderson","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1097\/qai.0000000000002854","article-title":"DigiPrEP: A pilot trial to evaluate the feasibility, acceptability, and accuracy of a digital pill system to measure PrEP adherence in men who have sex with men who use substances","volume":"89","author":"Chai","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B10","article-title":"Performance, reliability, usability, and safety of the ID-Cap system for ingestion event monitoring in healthy volunteers: A pilot study","volume":"13","author":"Flores","year":"2016","journal-title":"Innov Clin Neurosci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/tbm\/ibab117","article-title":"Development of a digital pill and respondent behavioral intervention (PrEPSteps) for HIV pre-exposure prophylaxis adherence among stimulant using men who have sex with men","volume":"12","author":"Chai","year":"2022","journal-title":"Transl Behav Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0000000000002574","article-title":"Oxycodone ingestion patterns in acute fracture pain with digital pills","volume":"125","author":"Chai","year":"2017","journal-title":"Anesth Analg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac280","article-title":"Supporting the Art: Medication adherence patterns in persons prescribed ingestible sensor-enabled oral pre-exposure prophylaxis to prevent human immunodeficiency virus infection","volume":"76","author":"Browne","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.4292","article-title":"Let visuals tell the story: Medication adherence in patients with type II diabetes captured by a novel ingestion sensor platform","volume":"3","author":"Browne","year":"2015","journal-title":"JMIR Mhealth Uhealth"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002891","article-title":"Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial","volume":"16","author":"Browne","year":"2019","journal-title":"PloS Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2196\/48971","article-title":"Formative perceptions of a digital pill system to measure adherence to heart failure pharmacotherapy: Mixed methods study","volume":"8","author":"Chai","year":"2024","journal-title":"JMIR Cardio"},{"key":"B17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1186\/s12879-022-07756-x","article-title":"Formative acceptance of ingestible biosensors to measure adherence to TB medications","volume":"22","author":"Vaz","year":"2022","journal-title":"BMC Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03594-9","article-title":"Real-world user experiences with a digital pill system to measure PrEP adherence: Perspectives from MSM with substance use","volume":"26","author":"Chai","year":"2022","journal-title":"AIDS Behav"},{"key":"B19","first-page":"1","article-title":"Preliminary feasibility of a wrist-worn receiver to measure medication adherence via an ingestible radiofrequency sensor","author":"Goldfine","year":"2023"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.07.011","article-title":"The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency","volume":"65","author":"Sim","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10447318.2018.1455307","article-title":"The System Usability Scale: Past, present, and future","author":"Lewis","year":"2018","journal-title":"Int J Hum-Comput Interact"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.026","article-title":"The PHQ-8 as a measure of current depression in the general population","volume":"114","author":"Kroenke","year":"2009","journal-title":"J Affect Disord"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.chb.2013.06.006","article-title":"The Media and Technology Usage and Attitudes Scale: An empirical investigation","volume":"29","author":"Rosen","year":"2013","journal-title":"Comput Hum Behav"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2003.09.041","article-title":"The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening","volume":"38","author":"Thompson","year":"2004","journal-title":"Prev Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00185.x","article-title":"The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility","volume":"97","year":"2002","journal-title":"Addiction"},{"key":"B27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1540-5915.2008.00192.x","article-title":"Technology acceptance model 3 and a research agenda on interventions","volume":"39","author":"Venkatesh","year":"2008","journal-title":"Decis Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03614-8","article-title":"\u2018I\u2019d feel like someone was watchin\u2019 me \u2026 watching for a good reason\u2019: perceptions of data privacy, access, and sharing in the context of real-time PrEP adherence monitoring among HIV-negative MSM with substance use","volume":"26","author":"Goodman","year":"2022","journal-title":"AIDS Behav"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/16094069231184123","article-title":"Use of Framework Matrix and Thematic Coding Methods in Qualitative Analysis for mHealth: The FluidCalc app","volume":"22","author":"Rosen","year":"2023","journal-title":"Int J Qual Methods"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-03082-y","article-title":"Design and delivery of real-time adherence data to men who have sex with men using antiretroviral pre-exposure prophylaxis via an ingestible electronic sensor","volume":"25","author":"Chai","year":"2021","journal-title":"AIDS Behav"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1550058\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:56:04Z","timestamp":1778853364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1550058\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":30,"alternative-id":["10.3389\/fpsyt.2026.1550058"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1550058","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"1550058"}}